Here, we demonstrate that the addition of the ATR inhibitor VX-970 both chemo and radio-sensitizes esophageal cancer cell lines in vitro and most importantly, that this translates to a significant tumor growth delay when combined with radiation in an in vivo model. The gene discussed is ATR; the disease is esophageal cancer.